Preterm birth: An overview of risk factors and obstetrical management

Amanda Stewart1, Ernest Graham

  • 1Department of Gynecology & Obstetrics, Division of Maternal Fetal Medicine, Johns Hopkins Hospital, Baltimore, Maryland. astewa30@jhmi.edu.

Insights

Preterm birth is a leading cause of infant death. Treatments like progesterone therapy and antenatal steroids aim to prevent preterm birth and improve infant outcomes.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Public Health

Background:

  • Preterm birth is the primary cause of neonatal mortality globally.
  • Identified risk factors include prior preterm birth, short cervix, infection, short interpregnancy interval, smoking, and race.
  • Emerging therapies like progesterone are increasingly used for high-risk mothers.

Purpose of the Study:

  • To review current strategies for managing and preventing preterm birth.
  • To highlight the role of progesterone therapy in at-risk pregnancies.
  • To discuss interventions for improving neonatal outcomes.

Main Methods:

  • Literature review of risk factors and management strategies for preterm birth.
  • Analysis of the efficacy of progesterone therapy.
  • Evaluation of tocolytics and medications for neonatal benefit.

Main Results:

  • Progesterone therapy is gaining traction for preventing preterm delivery in at-risk women.
  • Tocolytics may not prevent preterm birth but can extend pregnancy for critical medication administration.
  • Antenatal steroids, magnesium sulfate, and antibiotics are key interventions for neonatal health.

Conclusions:

  • Effective management of preterm birth requires addressing risk factors and utilizing appropriate therapies.
  • Progesterone therapy offers a promising approach for preventing preterm delivery.
  • A combination of interventions, including antenatal steroids and antibiotics, is crucial for optimizing neonatal outcomes.

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
545
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
45
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
604
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K